2021 annual financial data
Kyntra Bio 2021 Operating cash flow
Direct answer
Operating cash flow was -82,232,000 USD.
Operating income was -288,530,000 USD and net income was -290,023,000 USD.
Operating cash flow was -82,232,000 USD.
Get free Kyntra Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 235,309,000 USD
- Operating income
- -288,530,000 USD
- Net income
- -290,023,000 USD
- Operating cash flow
- -82,232,000 USD